[
  {
    "ts": "2025-10-14T17:11:23+00:00",
    "headline": "AbbVie (ABBV): Assessing Valuation After Strong 28% Year-to-Date Share Price Jump",
    "summary": "AbbVie (ABBV) shares have delivered solid gains for investors over the past year, rising 22%. The stock has continued its upward trend with a 28% jump year-to-date. The company's recent performance is drawing renewed investor attention. See our latest analysis for AbbVie. With momentum clearly building, AbbVie’s robust 28% share price return year-to-date has added to a steady 22% total return for shareholders over the past year. This reflects growing confidence in the company’s outlook amid...",
    "url": "https://finance.yahoo.com/news/abbvie-abbv-assessing-valuation-strong-171123877.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "6a32bd43-327b-3363-af74-ea47262ba888",
      "content": {
        "id": "6a32bd43-327b-3363-af74-ea47262ba888",
        "contentType": "STORY",
        "title": "AbbVie (ABBV): Assessing Valuation After Strong 28% Year-to-Date Share Price Jump",
        "description": "",
        "summary": "AbbVie (ABBV) shares have delivered solid gains for investors over the past year, rising 22%. The stock has continued its upward trend with a 28% jump year-to-date. The company's recent performance is drawing renewed investor attention. See our latest analysis for AbbVie. With momentum clearly building, AbbVie’s robust 28% share price return year-to-date has added to a steady 22% total return for shareholders over the past year. This reflects growing confidence in the company’s outlook amid...",
        "pubDate": "2025-10-14T17:11:23Z",
        "displayTime": "2025-10-14T17:11:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cbaG7tZ9A8mqrilci3AeIQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1OA9tdPdimVe1Dv1fa4MAQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-abbv-assessing-valuation-strong-171123877.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-abbv-assessing-valuation-strong-171123877.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-14T15:09:00+00:00",
    "headline": "Can Rinvoq and Skyrizi Sales Drive Another Strong Quarter for AbbVie?",
    "summary": "ABBV leans on booming Skyrizi and Rinvoq-driven sales to sustain growth and counter Humira's decline as Q3 results approach.",
    "url": "https://finance.yahoo.com/news/rinvoq-skyrizi-sales-drive-another-150900191.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "05439424-d185-3de8-9057-699182f02e92",
      "content": {
        "id": "05439424-d185-3de8-9057-699182f02e92",
        "contentType": "STORY",
        "title": "Can Rinvoq and Skyrizi Sales Drive Another Strong Quarter for AbbVie?",
        "description": "",
        "summary": "ABBV leans on booming Skyrizi and Rinvoq-driven sales to sustain growth and counter Humira's decline as Q3 results approach.",
        "pubDate": "2025-10-14T15:09:00Z",
        "displayTime": "2025-10-14T15:09:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OQG3.5Wd9P9R69q2rhm9rA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pBlncPVBhEXpjxtBDlEOsg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/rinvoq-skyrizi-sales-drive-another-150900191.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/rinvoq-skyrizi-sales-drive-another-150900191.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-14T10:09:56+00:00",
    "headline": "Does AbbVie's Latest AI Partnership Signal More Room for Its 2025 Rally?",
    "summary": "Thinking about whether to hold onto AbbVie stock, add more, or take some profits off the table? You're definitely not alone. AbbVie's been turning heads this year, with its share price notching a remarkable 28.3% gain since January and climbing 21.9% over the past 12 months. The momentum has been even more impressive over the long haul, up nearly 230% in five years. Those numbers suggest many investors are feeling more optimistic about AbbVie's growth potential or are reassessing the risks...",
    "url": "https://finance.yahoo.com/news/does-abbvies-latest-ai-partnership-100956635.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "ce311c1a-dd18-3523-ac50-bd76b4e0c181",
      "content": {
        "id": "ce311c1a-dd18-3523-ac50-bd76b4e0c181",
        "contentType": "STORY",
        "title": "Does AbbVie's Latest AI Partnership Signal More Room for Its 2025 Rally?",
        "description": "",
        "summary": "Thinking about whether to hold onto AbbVie stock, add more, or take some profits off the table? You're definitely not alone. AbbVie's been turning heads this year, with its share price notching a remarkable 28.3% gain since January and climbing 21.9% over the past 12 months. The momentum has been even more impressive over the long haul, up nearly 230% in five years. Those numbers suggest many investors are feeling more optimistic about AbbVie's growth potential or are reassessing the risks...",
        "pubDate": "2025-10-14T10:09:56Z",
        "displayTime": "2025-10-14T10:09:56Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cbaG7tZ9A8mqrilci3AeIQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1OA9tdPdimVe1Dv1fa4MAQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/does-abbvies-latest-ai-partnership-100956635.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/does-abbvies-latest-ai-partnership-100956635.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-14T04:39:04+00:00",
    "headline": "2 Profitable Stocks to Research Further and 1 We Avoid",
    "summary": "While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, \"Your margin is my opportunity\".",
    "url": "https://finance.yahoo.com/news/2-profitable-stocks-research-further-043904281.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "e9fb8ea1-bd1d-3252-92db-0ce44a85570c",
      "content": {
        "id": "e9fb8ea1-bd1d-3252-92db-0ce44a85570c",
        "contentType": "STORY",
        "title": "2 Profitable Stocks to Research Further and 1 We Avoid",
        "description": "",
        "summary": "While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, \"Your margin is my opportunity\".",
        "pubDate": "2025-10-14T04:39:04Z",
        "displayTime": "2025-10-14T04:39:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/f2612794ecd10445a4f2ff80ce149bb8",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "SFM Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OkxhQgsh1hIr08xowmnqZQ--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/f2612794ecd10445a4f2ff80ce149bb8.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hT6XC_W4Y.07W4HHeqbcOg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/f2612794ecd10445a4f2ff80ce149bb8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/2-profitable-stocks-research-further-043904281.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-profitable-stocks-research-further-043904281.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SFM"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "LAZ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]